Question 1

Where can I buy axatilimab?

Accepted Answer

axatilimab can be procured through GNH Pharmaceuticals USA LLC (https://gnh-usa.com/), a specialist in orphan drug supply and named patient programs. Visit https://gnh-usa.com/ or contact them directly for availability and pricing.

Question 2

How can I access axatilimab in my country?

Accepted Answer

axatilimab is available in 1 countries through named patient programs, compassionate use, and other regulatory pathways. Contact GNH Pharmaceuticals USA LLC at https://gnh-usa.com/ for country-specific access guidance.

Question 3

Is axatilimab an orphan drug?

Accepted Answer

Yes, axatilimab has Orphan Drug Designation, meaning it is approved for the treatment of rare diseases affecting small patient populations. Orphan drugs may be accessed through special named patient programs.

Question 4

What conditions does axatilimab treat?

Accepted Answer

axatilimab is indicated for: graft-versus-host disease, Chronic graft versus host disease. Chronic graft-versus-host disease

Generic Name	axatilimab
Brands	1 brand available
Active Ingredient	axatilimab
Drug Class	Chronic graft-versus-host disease
Manufacturer	Incyte / Syndax
Dosage Forms	Oral capsule
Orphan Status	Yes — Orphan Drug
Cold Chain	Required
Reg. Status	FDA Approved (2024)
Clinical Trial	NCT05117931
Countries	1 countries

Axatilimab

Description

Indications & Therapeutic Use

Global Availability (1 countries)

Available Through